Clinical trial
A Randomized, Double-Blind Active-Controlled, Dose-Ranging Study of the Safety and Efficacy of Chronically Administered MDL 28,574A in the Treatment of HIV-Infected Patients
NCT00002151
Study timeline
Registry last updated2005-06-24
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
HIV Infectionsunresolved
Interventions
Sponsors & collaborators
Hoechst Marion Roussellead sponsor
Mapped research locations
Fort LauderdaleFlorida, United States2HoustonTexas, United States1ChicagoIllinois, United States1Los AngelesCalifornia, United States1DallasTexas, United States1San FranciscoCalifornia, United States1PortlandOregon, United States1Washington D.C.District of Columbia, United States1DetroitMichigan, United States1RochesterNew York, United States1New OrleansLouisiana, United States1Kansas CityMissouri, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00002151 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.